2023 annual financial data
Castle Biosciences 2023 Operating margin
Castle Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was -30.93%.
Operating income was -67,977,000 USD and net income was -57,466,000 USD.
Operating cash flow was -5,626,000 USD.
Get free Castle Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 219,788,000 USD
- Operating income
- -67,977,000 USD
- Net income
- -57,466,000 USD
- Operating cash flow
- -5,626,000 USD